Zelira Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.530x

Zelira Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, Zelira Therapeutics Ltd (ZLD) has a cash flow conversion efficiency ratio of 0.530x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.61 Million USD) by net assets (AU$-4.29 Million ≈ $-3.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zelira Therapeutics Ltd (2004–2025)

Cash flow conversion efficiency of Zelira Therapeutics Ltd from 2004 to 2025. This chart illustrates how Zelira Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zelira Therapeutics Ltd stock price for real-time trading data and today's change.

Zelira Therapeutics Ltd Cash Flow Conversion Ratio Explained

Zelira Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zelira Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zelira Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see market cap of Zelira Therapeutics Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
mTouche Technology Bhd KLSE:0092	-0.178x
Orestone Mining Corp V:ORS	-0.048x
CASA DE BUCOVINA-CLUB DE MUNTE RO:BCM	-0.009x
Exact Therapeutics AS OL:EXTX	-0.697x
Ho Wah Genting Bhd KLSE:9601	-0.345x
Niki BioSolutions, Inc. NASDAQ:NIKI	-0.039x
First Helium Inc V:HELI	0.009x
CKH Food & Health Limited KQ:900120	0.011x

Annual Cash Flow Conversion Efficiency for Zelira Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Zelira Therapeutics Ltd from 2004 to 2025. Review cash generation quality of Zelira Therapeutics Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-4.29 Million ≈ $-3.04 Million	AU$-4.91 Million ≈ $-3.47 Million	1.144x	+8.76%
2024-06-30	AU$-4.17 Million ≈ $-2.95 Million	AU$-4.39 Million ≈ $-3.11 Million	1.052x	+560.04%
2023-06-30	AU$31.71 Million ≈ $22.44 Million	AU$-7.25 Million ≈ $-5.13 Million	-0.229x	+13.46%
2022-06-30	AU$35.69 Million ≈ $25.25 Million	AU$-9.43 Million ≈ $-6.67 Million	-0.264x	-15.97%
2021-06-30	AU$37.83 Million ≈ $26.77 Million	AU$-8.62 Million ≈ $-6.10 Million	-0.228x	-13.45%
2020-06-30	AU$34.55 Million ≈ $24.44 Million	AU$-6.94 Million ≈ $-4.91 Million	-0.201x	+81.34%
2019-06-30	AU$3.11 Million ≈ $2.20 Million	AU$-3.34 Million ≈ $-2.37 Million	-1.076x	-154.74%
2018-06-30	AU$6.21 Million ≈ $4.40 Million	AU$-2.62 Million ≈ $-1.86 Million	-0.422x	-51.54%
2017-06-30	AU$7.90 Million ≈ $5.59 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.279x	-117.04%
2016-06-30	AU$-202.91K ≈ $-143.57K	AU$-331.82K ≈ $-234.78K	1.635x	+299.81%
2015-06-30	AU$357.87K ≈ $253.22K	AU$-292.89K ≈ $-207.24K	-0.818x	-122.24%
2014-06-30	AU$750.16K ≈ $530.78K	AU$-276.25K ≈ $-195.47K	-0.368x	-47.42%
2013-06-30	AU$1.04 Million ≈ $736.13K	AU$-259.89K ≈ $-183.89K	-0.250x	+41.03%
2012-06-30	AU$1.35 Million ≈ $956.78K	AU$-572.82K ≈ $-405.31K	-0.424x	-374.87%
2011-06-30	AU$661.35K ≈ $467.95K	AU$101.92K ≈ $72.12K	0.154x	+108.53%
2010-06-30	AU$654.33K ≈ $462.98K	AU$-1.18 Million ≈ $-836.78K	-1.807x	-185.06%
2009-06-30	AU$2.48 Million ≈ $1.75 Million	AU$-1.57 Million ≈ $-1.11 Million	-0.634x	+63.41%
2008-06-30	AU$1.28 Million ≈ $902.96K	AU$-2.21 Million ≈ $-1.56 Million	-1.733x	-273.67%
2007-06-30	AU$-14.84 Million ≈ $-10.50 Million	AU$-14.81 Million ≈ $-10.48 Million	0.998x	+309.39%
2006-06-30	AU$14.88 Million ≈ $10.53 Million	AU$-7.09 Million ≈ $-5.02 Million	-0.476x	-83.61%
2005-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-2.56 Million ≈ $-1.81 Million	-0.260x	+21.82%
2004-06-30	AU$8.29 Million ≈ $5.87 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.332x	--

About Zelira Therapeutics Ltd

AU:ZLD Australia Biotechnology

Market Cap

$4.65 Million

AU$6.57 Million AUD

Market Cap Rank

#28644 Global

#1517 in Australia

Share Price

AU$0.50

Change (1 day)

+0.00%

52-Week Range

AU$0.33 - AU$0.91

All Time High

AU$26.25